Discover
HRTX
Heron Therapeutics, Inc.
0.42
1 x 0.36
1 x 0.48
bid
ask
-
0.00
0.56%
1 @ 04:00 PM
0.42 -0.00 (1.04%)
| Ytd | -67.35% | |
| 1y | -80.44% |
0.42
day range
0.44
0.38
52 week range
2.30
| Open | 0.42 | Prev Close | 0.43 | Low | 0.42 | High | 0.44 | Mkt Cap | 80.33M |
| Vol | 3.77M | Avg Vol | 3.18M | EPS | -0.18 | P/E | N/A | Forward P/E | 178.00 |
| Beta | 1.81 | Short Ratio | 14.20 | Inst. Own | 81.53% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-07 | 50-d Avg | 0.77 | 200-d Avg | 1.07 | 1yr Est | 6.00 |
| Income Statement | |||
| Total Revenue | 34.71M | ||
| Revenues (USD) | 34.71M | ||
| Cost of Revenue | 10.64M | ||
| Gross Profit | 24.07M | ||
| Operating Expenses | 28.84M | ||
| Research and Development Expense | 2.38M | ||
| Selling, General and Administrative Expense | 26.45M | ||
| Operating Income | -4.76M | ||
| Net Income | -8.11M | ||
| Net Income Common Stock | -8.11M | ||
| Net Income Common Stock (USD) | -8.11M | ||
| Consolidated Income | -8.11M | ||
| Earnings per Basic Share | -0.04 | ||
| Earnings per Basic Share (USD) | -0.04 | ||
| Earnings per Diluted Share | -0.04 | ||
| Earning Before Interest & Taxes (EBIT) | -8.11M | ||
| Earning Before Interest & Taxes (USD) | -8.11M | ||
| Weighted Average Shares | 189.65M | ||
| Weighted Average Shares Diluted | 189.65M | ||
| Balance Sheet | |||
| Cash and Equivalents | 26.12M | ||
| Cash and Equivalents (USD) | 26.12M | ||
| Investments | 18.67M | ||
| Investments Current | 18.67M | ||
| Trade and Non-Trade Receivables | 83.69M | ||
| Current Assets | 228.98M | ||
| Property, Plant & Equipment Net | 12.03M | ||
| Total Assets | 246.22M | ||
| Total Debt | 141.63M | ||
| Current Liabilities | 90.52M | ||
| Debt Non-Current | 141.63M | ||
| Total Liabilities | 237.08M | ||
| Accumulated Retained Earnings (Deficit) | -1.95B | ||
| Accumulated Other Comprehensive Income | -6.00K | ||
| Shareholders Equity | 9.14M | ||
| Shareholders Equity (USD) | 9.14M | ||
| Assets Non-Current | 17.23M | ||
| Total Debt (USD) | 141.63M | ||
| Inventory | 92.54M | ||
| Liabilities Non-Current | 146.56M | ||
| Trade and Non-Trade Payables | 8.97M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 529.00K | ||
| Net Cash Flow from Financing | -51.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.53M | ||
| Capital Expenditure | -391.00K | ||
| Net Cash Flow from Investing | -939.00K | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -548.00K | ||
| Net Cash Flow from Operations | -1.54M | ||
| Share Based Compensation | 2.98M | ||